Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kala Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kala Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Kala Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is KALA. The reporting company's CIK number is 1479419.
The total value of stock buying since 2005 is $30,464,985.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $190,268.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-08-11||Brazzell Romulus K (Chief Medical Officer)||Option Ex||108,725||1.75||190,268|
|2017-07-25||Shah Rajeev M.||Buy||533,333||15.00||7,999,995|
|2017-07-25||Longitude Venture Partners Ii, L.p. (10% Owner)||Buy||215,000||15.00||3,225,000|
|2017-07-25||Isaly Samuel D||Buy||319,333||15.00||4,789,995|
Insider trading activities including stock purchases, stock sales, and option exercises of KALA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kala Pharmaceuticals, Inc. (symbol KALA, CIK number 1479419) see the Securities and Exchange Commission (SEC) website.